ARCHIVES

Also in this 8-page issue: The Cancer Letter wins two awards for its “authoritative examination” of NCI.

This article is from The Cancer Letter archive.

Vol. 30 No. 24 | June 11, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Plans $38 Million For New Research In Tobacco Control Over Next Two Years

October 16, 1998

NCI Raises R01 Payline To 16th Percentile FY09. Coalition Formed To Advocate For Medical Innovation

March 27, 2009

Black Men Face Disparate Cancer Burden; Minority Rates Vary, Klausner Tells House

April 3, 1998

The Lancet Oncology Retracts Potti Paper, NEJM Doesn’t

February 4, 2011

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

May 30, 2014